Initiation of phase 1 trial of remyelinating antibody

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Initiation of phase 1 trial of remyelinating antibody

Postby MSUK » Tue Apr 23, 2013 11:49 pm

Initiation of phase 1 trial of remyelinating antibody in people with MS

Mayo Clinic and Acorda Therapeutics, Inc. announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis (MS). This is a Phase 1 clinical trial enrolling people with MS to assess the safety and tolerability of rHIgM22. The study also includes several exploratory efficacy measures....... Read More -http://www.ms-uk.org/index.cfm/myelin
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service